Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
2 types of diarrhea, microbial classification
|
Enterotoxin (secretory) vs Mucosal invasion (invasive) diarrhea
|
|
Clinical categories of diarrhea
|
Acute watery and presistent dysentary
|
|
2 classes of Acute watery diarrhea
|
altered intestinal motility and osmotic
|
|
Persistent dysentery classes
|
secretory and exudative
|
|
Diarrheas covered
|
Traveler's, salmonellosis, campylobacteriosis, enterotoxic E. coli, viral gasteroenteritis, c. difficile food poisoning
|
|
Travelor's diarrhea onset / duration
|
5-15 days / 1-5days
|
|
Treveler's diarrhea etiology
|
E. coli, shigella
|
|
Traveler's diarrhea symptoms
|
malaise, abdominal cramps, sudden watery diarrhea
|
|
Traveler's diarrhea initial tx
|
loperamide prn max 16mg/day x2 days
|
|
Traveler's diarrhea PO abx if needed
|
If high risk of infection, bismuth subsalicylate (inhibits enterotoxin activity)
TMP/SMX FQ - norfloxacin and ciprofloxacin Azithromycin |
|
Campylobacteriosis treatment and duration
|
FQ
Azithromycins 5 days if needed |
|
Traveler's diarrhea prophylaxis
|
bactrin, fq, bismuth subsalicylate
|
|
Salmonellosis s/s
|
enterocolitis with high fever and diarrhea
|
|
Antimotility agents contraindicated in:
|
Enterotoxic E. coli
Campylobacteriosis |
|
C. difficile risk factors
|
AB (FQ, cephs, clindamycins, pens), medications (PPI, h2ra, nsaids, laxatives, narcs, antiperistaltic), older age, chemo
|
|
C. difficile diagnosis
|
ABx w/i 3 months, onset after 72hrs, risk factors, characteristic diarrhea
|
|
C. difficile diarrhea characteristics
|
Watery, foul smelling, blood, green, or yellow, quantity
|
|
C. difficile dx
|
cytotoxic assay (gold standard, 48hr min)
culture immunologic (4 hrs) endoscopy |
|
C. difficile tx
|
d/c offending agent
metronidazole 10-14days |
|
C. difficile tx alt (mod-severe)
|
alt: vancomycin (mod-severe)
|
|
Enterotoxic E. coli treatment
|
Fluids
Rarely ABx Potential vaccine |